Figure 1From: A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors Mean (standard deviation) serum concentration profiles on day 2 of cycle 1. Back to article page